Colonoscopy & Lower GI Endoscopy

Office anorectal examination through full colonoscopy: technique, instrumentation, bowel preparation, sedation, quality measures, complications, and training. Synthesized from ASCRS Ch. 4. Textbook reference content, not primary literature. Complements Anorectal Physiology Testing (the physiology-lab side of anorectal diagnostics) and Rectal Cancer (which already covers ERUS/MRI staging clinically — the ERUS accuracy figures below corroborate and quantify that page's qualitative description).

Anorectal examination

Office exam performed prone jackknife (best exposure, needs a proctoscopic table; avoid in decreased mobility, recent abdominal surgery, morbid obesity, late pregnancy, arthritic knees/hips/back) or left lateral decubitus/Sim's position (more accessible, somewhat worse visualization, especially in obese patients). Sequence: inspection/palpation of perineum/anal margin/verge → digital rectal exam (DRE) → anoscopy → proctoscopy as indicated. DRE should be omitted for anal fissure (see Anal Fissure), thrombosed external hemorrhoids, non-reducible internal hemorrhoids, tight anal stricture (see Anal Stenosis), or a large anorectal mass; the traditional teaching to avoid DRE in neutropenia (translocation risk) has little supporting data and neutropenia is now considered only a relative contraindication.

Anoscopy: simple, inexpensive, visualizes the anal canal/distal rectum; well tolerated except with fissure/thrombosed hemorrhoid. No prep or sedation needed. Enables biopsy and therapeutic procedures (hemorrhoid banding, sclerotherapy) at the same setting.

Rigid proctoscopy: evaluates the anorectum up to the distal sigmoid (~20 cm from the anal verge), particularly useful for precisely localizing a rectal lesion's distance from the verge (relevant to Rectal Cancer and Low Anterior Resection Syndrome (LARS) planning). No sedation required; contraindicated in fissure, thrombosed hemorrhoids, anal stenosis, recent anorectal surgery. Has declined in use as flexible endoscopy access has improved — a skill gap the chapter flags among more recently trained colorectal surgeons.

Endoanal/endorectal ultrasound (EAUS/ERUS): transanal 360° circumferential imaging, no sedation needed. EAUS evaluates the anal sphincter complex/pelvic floor — sensitivity/specificity for locating a sphincter defect approaches 100%, making it the go-to imaging for Fecal Incontinence workup; also identifies/characterizes abscesses and fistulas (hydrogen peroxide instillation via an external fistula opening can improve tract visualization). ERUS is used for rectal cancer staging: accuracy 66–92% for tumor depth (T-stage) and 64–88% for regional nodal status — quantifies what Rectal Cancer already states qualitatively (ERUS provides accurate T-stage, weaker nodal accuracy). MRI has largely replaced ERUS for preoperative rectal cancer staging, though ERUS retains a role in staging superficial neoplasia. Five rectal-wall layers are visible on ERUS, defining the uT-stage (uT1 = submucosal invasion only, uT2 = into but not through muscularis propria, uT3 = through muscularis propria into perirectal fat with a "scalloped" appearance, uT4 = direct invasion of adjacent organs). Main disadvantage: operator-dependent, raising reliability/reproducibility concerns. See Colorectal Cancer Staging (TNM) for the T1 sm1/sm2/sm3 submucosal-invasion subdivision (relevant to local-excision candidacy), a broader T-stage/nodal accuracy range from a different ASCRS chapter (reported alongside, not merged with, the figures above), and full MRI-based staging detail (CRM, EMVI, T3 subclassification) that this page doesn't cover.

Flexible endoscopy technique fundamentals

Core maneuvers, used for both flexible sigmoidoscopy and colonoscopy: torque (twisting the shaft to stiffen the scope and redirect the tip — "gentle" torque keeps the scope straight, "forceful" torque removes/pushes through a loop), tip deflection (keeping the tip centered in the lumen via the angulation knobs), dithering/jiggle (rapid shaft movements that "accordion" the colon onto the scope to shorten it — useful combined with torque and in-and-out movement), air aspiration (judicious suction can "pull" the tip around a flexure without pushing/looping), and slide-by (pushing blindly into a turn with maximum tip deflection, without full visualization — controversial given perforation risk; should never be performed by unsupervised trainees, and should be terminated immediately if resistance increases or the mucosa blanches at the tip).

Flexible sigmoidoscopy (FS)

Office-based, no sedation typically needed; scope length 60–71 cm, reaches the descending colon/splenic flexure in ~80% of exams. Detects 65–75% of polyps and 50–65% of colorectal cancer — not a substitute for screening colonoscopy, since it misses lesions proximal to the distal transverse colon/splenic flexure. Indications: unexplained rectal bleeding, suspected proctitis, localizing a rectal/rectosigmoid tumor (less reliable than rigid proctoscopy for this), evaluating response to neoadjuvant chemoradiation, postoperative anastomosis evaluation (stricture/recurrence), and monitoring after local excision with a complete clinical response (watch-and-wait — see Rectal Cancer). Polyps found on FS should prompt a full colonoscopy to assess the proximal colon. Most common complication: abdominal pain/bloating from overdistention/air trapping; perforation is exceedingly rare (as low as 0.002%), typically at the distal sigmoid where it angulates from the fixed rectum at the sacral promontory.

Colonoscopy

Bowel preparation

No ideal prep yet exists (safe, effective, tolerable, and reliably completed) — roughly a quarter of US/Western European colonoscopies have an inadequate-quality prep, which lowers adenoma detection rate (ADR), lengthens procedures, and increases cost. Three categories:

• Iso-osmotic: PEG-electrolyte lavage solution (PEG-ELS) is the "gold standard" (4 L, but poor palatability limits compliance — up to 15% can't complete it); sulfate-free and low-volume (2 L, with ascorbic acid) formulations improve tolerance with similar efficacy. PEG-3350/MiraLAX combined with a sports-drink electrolyte solution is widely used off-label (not FDA-approved for this indication) for its low cost/better tolerance.
• Hyperosmotic: magnesium citrate, sodium sulfate, sodium phosphate. Sodium phosphate's aqueous form was voluntarily withdrawn from market (nephrocalcinosis/renal failure risk); its tablet form remains available by prescription but carries an FDA box warning against use in elderly patients and those with GI motility, renal/liver, or heart disease. Sodium picosulfate + magnesium citrate is a popular low-volume alternative.
• Regardless of agent, split-dose regimens (a portion the evening before, the rest 3–8 hours before the procedure, completed ≥2 hours before sedation per ASA guidelines) consistently produce higher-quality preps and better ADR/tolerance than single-dose — the current standard of practice per ASGE, even for the 4 L PEG-ELS prep (FDA-approved only for single-dose use, but split-dose use is evidence-supported off-label).

Special considerations: a low-quality prep (can't detect lesions <0.5 cm) should prompt an early repeat colonoscopy. Prophylactic antibiotics are not routinely recommended (2015 ASGE guidelines) — an exception is peritoneal-dialysis patients, where ISPD recommends periprocedural IV ampicillin+aminoglycoside (±metronidazole) to reduce peritonitis risk. Anticoagulation management: screening colonoscopy (even with biopsy) is low-risk for bleeding and almost all anticoagulants can be continued; polypectomy is high-risk, but the need often isn't known in advance. Aspirin/NSAIDs generally needn't be held; thienopyridines (clopidogrel) are typically stopped 5–7 days before, warfarin 5 days before, LMWH 12 hours before, factor Xa/direct thrombin inhibitors 1–5 days before (half-life dependent) — bridging with LMWH has been shown non-inferior to no bridging for thromboembolism prevention while tripling major bleeding risk.

Sedation

Most US colonoscopies use some sedation, most commonly endoscopist-directed moderate sedation (benzodiazepine + opiate) — disadvantages include time-to-adequate-sedation, poor recall/intra-procedural amnesia is not guaranteed, prolonged recovery, and post-procedural emesis; one study found 45% of "moderate sedation" patients were actually at a deeper sedation level at some point, with reversal agents (naloxone, flumazenil) needing to be readily available. Propofol (GABA-mediated) offers faster onset/recovery, better amnesia, and better satisfaction, but traditionally requires a dedicated anesthesia provider — driving a documented cost shift (anesthesia services rose from ~1/3 to ~1/2 of US colonoscopies 2009→2013, an estimated $1.5B/year), though growing evidence supports its safety when administered by endoscopist-supervised registered nurses.

Instrumentation

Colonoscope length 133–170 cm; standard adult outer diameter 12.8–13.2 mm (pediatric 11.6–11.7 mm, neonatal 9.7–9.8 mm also available). Components: suction channel, air/water insufflation channel, fiberoptic light bundles, biopsy/working channel, angulation control knobs. Some models add a second working channel for advanced therapeutics; most modern scopes have variable stiffness control.

Colonoscopy technique

Left lateral decubitus position, informed consent (plus separate sedation consent if anesthesia services used), DRE before scope insertion. The scope is advanced through the rectum (navigating the valves of Houston) to the rectosigmoid junction — often an acute angle, worse if the sigmoid is fixed by prior pelvic surgery (especially hysterectomy). The sigmoid colon is the most tortuous segment (high tone, frequent spasm, most diverticulosis-prone — see Diverticulitis) and the most frequent site of colonoscopic perforation; slide-by maneuvers should be avoided here especially. Technique: short advance/withdraw cycles with slight clockwise torque and tip deflection; loop reduction via withdrawal/torque before pushing further; a vasovagal response (bradycardia) during a difficult sigmoid push warrants withdrawal to reduce the loop. Large diverticula can be mistaken for the true lumen — frequent pull-back is needed to reorient in a diverticula-riddled sigmoid.

Passage into the descending colon is usually straightforward (straighter, less muscular than sigmoid); the splenic flexure may show the spleen's blue shadow through the wall; the transverse colon has a characteristic triangular lumen (formed by the taeniae) and can be redundant/pelvis-descending, especially after pelvic surgery — external abdominal pressure assists advancement here. The hepatic flexure shows the liver's blue shadow; beyond it, novice endoscopists often mistake a sharply angulated "fool's cecum" area for the true cecum. The ileocecal valve appearance is highly variable (fold, polypoid yellowish mass, visible lumen, or hidden); the true cecum is confirmed by the "crow's foot" muscular pattern around the appendiceal orifice — photodocumentation of the ileocecal valve and appendiceal orifice (plus terminal ileum if intubated) is mandatory for quality assurance. Transillumination/external right-lower-quadrant pressure visualization is not a reliable substitute for direct landmark visualization.

Terminal ileal intubation: routine role is debated — one study found successful intubation in 90.2% of attempts but clinically significant findings in only 3.3% of asymptomatic patients; another found gross abnormalities in only 1%. Others argue routine ileoscopy is still worthwhile given potentially significant incidental findings (e.g., terminal ileal carcinoid tumors). Terminal ileal mucosa is distinguishable from colonic mucosa by its granular appearance and increased motility; lymphoid follicles (especially in younger patients) can resemble small polyps.

Withdrawal: slow, methodical, examining behind mucosal folds (the scope tip can flatten/splay folds). Routine rectal retroflexion on withdrawal is controversial — doesn't increase detection of clinically important neoplasia, but can help evaluate anorectal bleeding sources; can cause discomfort/superficial mucosal trauma and, rarely, rectal perforation.

Alternative techniques

• Carbon dioxide insufflation: absorbed through gut mucosa much faster than air, reducing prolonged bowel distention — improves patient comfort and is advantageous when combined with laparoscopy (less bowel distention limiting the surgical field) and in patients with incompetent ileocecal valves at risk of massive small-bowel distention.
• Water insufflation: decreases pain and loop formation, aids stabilization during resection of large polyps — but associated with higher rates of incomplete colonoscopy and (per a recent comparative study) higher adenoma miss rate vs. CO₂.
• Chromoendoscopy (indigo carmine dye spray): enhances mucosal contrast/pit-pattern assessment, especially valuable for surveillance in IBD (see Ulcerative Colitis, Crohn Disease) where dysplastic lesions tend to be flat/inconspicuous; improves flat-adenoma detection on screening colonoscopy at the cost of longer procedure time.
• Narrow band imaging (NBI): filters to enhance mucosal microcapillary visualization — adenomas appear brown/hypervascular, serrated polyps pale/hypovascular against normal mucosa; higher ADR than white light, similar yield to chromoendoscopy for UC-associated neoplasia detection.
• Full-spectrum endoscopy (FUSE): side-mounted lenses give up to a 330° field of view to reduce miss rate — initial studies showed a decreased adenoma miss rate, but subsequent studies were mixed, and cost has limited adoption.

Difficult exams

Adjunctive maneuvers when loop formation blocks advancement: changing patient position (supine can ease a difficult sigmoid or aid ascending-colon-to-cecum advancement with backstream looping; right-side or prone positioning occasionally helps); abdominal pressure (an assistant splints redundant colon — most effective for sigmoid/transverse loops, applied gradually to avoid rapid intraabdominal pressure changes); rotating the scope (torque + 180° rotation while keeping the tip centered, to change the angle of approach to a difficult angulation).

Incomplete colonoscopy

Occurs in 4–25% of exams for various reasons. If due to inadequate prep, repeat colonoscopy after better preparation (imaging is not an adequate substitute if the prep itself was insufficient). If due to anatomic difficulty (redundant colon, adhesions, stricture): try anesthesia-assisted sedation, different scope caliber, CO₂/water insufflation, fluoroscopy, or balloon-assisted colonoscopy. CT colonography ("virtual colonoscopy") has largely replaced double-contrast barium enema as the follow-up imaging option — sensitivity 96% for cancer, 67–94% for advanced adenomas ≥1cm, 73–98% for advanced adenomas ≥6mm — but requires another bowel prep and colonic distention, and one recent study found it inferior to repeat colonoscopy by an expert endoscopist specifically for the incomplete-exam scenario. MR colonography (traditionally an IBD-evaluation tool) is increasingly used for polyp detection given radiation-exposure concerns with repeat CT.

Complications

More than 15 million colonoscopies are performed annually in the US, the vast majority complication-free.

• Bowel-prep complications: nephrocalcinosis/renal failure (historically with sodium phosphate, now largely avoided); nausea/vomiting with PEG (can occasionally signal upper GI pathology); aspiration risk in elderly/gastroparesis patients; electrolyte abnormalities with non-osmotically- balanced solutions (rarely clinically significant).
• Sedation/anesthesia complications: a 2016 claims-data review found anesthesia services used in 34% of colonoscopies, associated with a 13% risk of any complication within 30 days (perforation, hemorrhage, abdominal pain, anesthesia-specific complications, stroke); propofol can suppress cardiac output/cause hypotension; vasovagal reactions occur in up to 16% of cases (overdistention/ mesenteric traction from looping — resolve with air aspiration and loop reduction); true cardiac arrhythmias are rare and usually self-limited (electrolyte/hypovolemia-related). Anesthesia assistance for outpatient colonoscopy is independently associated with increased aspiration pneumonia risk (OR 1.63) in a large Canadian cohort study.
• Perforation: pooled prevalence ~0.05% for all colonoscopies, 0.08% with polypectomy — though older studies reported up to 5% for therapeutic exams. Mechanisms: direct scope trauma (sigmoid colon accounts for 64–74% of direct-trauma perforations, often from slide-by maneuvers at sharp angulation or diverticula), overdistention/barotrauma (up to 35% of perforations, more common in the thin-walled proximal ascending colon/cecum — CO₂ insufflation is thought protective here), or therapeutic intervention (polypectomy, dilation). Risk factors: severe diverticular disease with muscular hypertrophy/luminal narrowing (cross-reference Diverticulitis), severe IBD, colonic ischemia (cross-reference Ischemic Colitis), and prior abdominopelvic surgery. Management depends on etiology/clinical status: diffuse peritonitis → emergent exploration; adequate prep + minimal contamination + stable patient → laparoscopic primary repair/resection often acceptable; a well-recognized perforation during a therapeutic colonoscopy without peritonitis may be managed nonoperatively (bowel rest + IV antibiotics, 33–90% success) or with endoscopic clip closure (59–100% success when recognized promptly). Perforations recognized during/immediately after the procedure have better prognosis than delayed recognition. The chapter explicitly frames abandoning a difficult colonoscopy as acceptable, not a "failure" — incomplete exams should be preferred over perforation risk.
• Post-polypectomy bleeding: 0.3–6.1% of colonoscopies (0.3% after purely diagnostic exams). Risk factors: polyp size >2cm (4.5-fold higher for polyps >10mm vs. <10mm; graded risk by size: 0.4% for <10mm, 1.6% for 10–19mm, 3.8% for 20–29mm, 5.3% for >29mm), thick stalk, right-colon location, resumed antithrombotic/anticoagulant therapy, cardiovascular disease, hypertension. "Hot biopsy" (electrocautery) does not reduce bleeding risk and may increase it (submucosal coagulation injury to submucosal arteries causing delayed bleeding). Management: resuscitation if significant hemorrhage/instability; repeat colonoscopy with endoscopic hemostasis (clips, cautery, epinephrine injection) for continued bleeding; angiographic embolization as an alternative; surgery almost never required.
• Post-polypectomy syndrome: transmural electrocautery burn causing localized peritonitis symptoms (pain, fever, leukocytosis) without radiographic perforation. Incidence 0.003–0.1% of all colonoscopies, rising to ~1% after EMR and 7–8% after ESD. Presents 1–5 days post-procedure, managed with IV fluids/broad-spectrum antibiotics/bowel rest; surgery almost never needed; rare progression to full-thickness perforation.
• Splenic injury: rare (estimated 1:100,000, though likely underreported — a 2016 systematic review found 172 reported cases), from traction on the splenocolic ligament; more common in females and patients with prior abdominopelvic surgery. Typically subcapsular hematoma, occasionally rupture with hemoperitoneum/hemorrhagic shock. Splenic artery embolization is gaining favor over splenectomy in hemodynamically stable patients.
• Infectious complications: bacteremia in 2–4% of colonoscopy+polypectomy patients, but clinically significant infective endocarditis is exceedingly rare (prophylaxis for "high-risk" cardiac conditions is now discretionary, not required). Contaminated-scope infection transmission risk estimated at 1:1.8 million (Salmonella, Pseudomonas, Mycobacterium most commonly implicated, via biofilm formation on inner channel surfaces resistant to decontamination).

The endoscopy unit

Reprocessing: CDC-recommended multistep process (immediate precleaning, leak testing, manual high-level-disinfectant cleaning with brushing/flushing of all channels, final visual inspection, automated endoscope reprocessing, surveillance culturing) — lapses in reprocessing are a leading contributor to the (likely underestimated) infection rate, historically estimated near 1:1.8 million procedures by ASGE (1993) but felt closer to 1:276,000 more recently. Reprocessing/repair costs per colonoscopy range from $101 (high-volume centers) to $280 (low-volume centers), motivating growing interest in disposable flexible endoscopes.

Efficiency: discrete event simulation (DES) modeling has been used to optimize room/staff allocation and quantify the cost of no-show patients (one study: an 18% no-show rate costs ~$725/day vs. a theoretical $4,433/day gain at perfect attendance) — a reminder call 7 days pre-procedure dropped one institution's no-show rate from 16.5% to 12.8%.

Quality measures

Cecal intubation rate, photodocumentation, screening intervals, bowel prep quality, withdrawal time, and adenoma detection rate (ADR) are the current standard quality metrics — ADR and withdrawal time have received the most study attention.

• Withdrawal time: US Multi-Society Task Force benchmark ≥6 minutes for screening colonoscopy without biopsy/other maneuvers (2002); more recent data suggest 9 minutes increases both adenoma and serrated-lesion detection. Easily gamed (miscounting cecal-intubation time, redundant re-examination of the same segment, "parking" the scope) without actually improving detection — a acknowledged limitation of the metric.
• ADR: fraction of patients ≥50 undergoing first-time primary screening colonoscopy with ≥1 adenoma detected. Preferred over malignancy detection rate (negates colonoscopy's screening purpose) or polyp detection rate (gameable via hyperplastic/benign polyp counting). Current benchmarks: ≥30% (male patients), ≥20% (female patients), ≥25% (mixed population). Limitations: restricted to patients >50 and only the first colonoscopy by strict criteria (some argue this should expand); can perversely incentivize "one-and-done" behavior (stopping careful examination after the first polyp is found, since only one polypectomy is typically reimbursed per exam) — motivating interest in adenomas per colonoscopy (APC) as a metric that would reward thorough full-colon examination instead.

Leasing vs. purchasing endoscopy equipment

Purchasing preserves equity/potential long-term cost savings and avoids recurring contract negotiation, but exposes the unit to the full cost of repairs once warranties expire. Leasing allows more frequent equipment refresh, typically bundles maintenance/repair coverage, and can ease cash flow for new practices/facilities — at the cost of never building equity. The chapter frames the long-term financial comparison as genuinely difficult to model given uncertain procedural volumes, payor mix, warranty terms, and technology-change pace.

Training and simulation

Endoscopy is an increasingly required competency for general surgery residents, not just colorectal surgery fellows — the ABS Flexible Endoscopy Curriculum (FEC), including SAGES's Fundamentals of Endoscopic Surgery (FES) certification (a multiple-choice exam plus a 5-part manual skills exam on a virtual-reality platform), is now required before General Surgery board eligibility (class of 2017–2018 onward). ACGME minimum case requirements: 50 colonoscopies for General Surgery, 140 for colorectal surgery (≥30 interventional) — though the chapter stresses that hitting a minimum case count is not the same as achieving proficiency (one study found gastroenterology fellows didn't reach 90% independent completion until 500 colonoscopies performed). Simulation builds baseline dexterity and familiarity but cannot replace real-patient experience, and teaching endoscopy poses a unique challenge versus open/laparoscopic surgery: when difficulty or patient safety is threatened, the supervisor must take over the scope, costing the trainee the learning opportunity at exactly the moment of greatest educational value. The Global Assessment of Gastrointestinal Endoscopic Skills (GAGES) scale standardizes evaluator feedback across five domains: scope navigation, use of strategies, ability to keep a clear endoscopic field, instrumentation (if applicable), and quality of examination.

Related pages

• Anorectal Physiology Testing — the physiology-lab counterpart to this page's imaging/endoscopic diagnostics (EAUS, defecography already covered there).
• Rectal Cancer — ERUS staging accuracy figures here quantify that page's existing qualitative ERUS/MRI comparison.
• Colorectal Cancer Staging (TNM) — sm1/sm2/sm3 T1 subdivision, a second ERUS accuracy-figure citation, and the full MRI-based staging detail (CRM, EMVI) this page doesn't cover.
• Colorectal Cancer Screening — flexible sigmoidoscopy/colonoscopy as screening tools (distinct from this page's diagnostic/staging endoscopy focus).
• Fecal Incontinence — EAUS's near-100% sensitivity/specificity for sphincter defects is the primary imaging tool for this workup.
• Diverticulitis, Ischemic Colitis — both cited here as colonoscopic-perforation risk factors.
• Ulcerative Colitis, Crohn Disease — chromoendoscopy/NBI surveillance relevance for dysplasia detection in IBD.

Open items / gaps

• No primary literature yet on any of the specific trials cited for bowel-prep comparisons, ADR benchmarks, or the propofol-administration safety studies — presented here as the textbook's own literature synthesis.
• The interaction between local excision technique (see Local Excision of Rectal Neoplasms) and this chapter's ESD/EMR description is not cross-referenced in the source — worth double-checking for consistency (informal read: consistent, same techniques described from different angles) if either page is revised later.